(NOC) Northrop Grumman - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6668071029
Stock: Aircraft, Missiles, Satellites, Sensors, Cyber
Total Rating 69
Risk 83
Buy Signal 0.51
| Risk 5d forecast | |
|---|---|
| Volatility | 33.6% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.67 |
| Alpha | 59.35 |
| Character TTM | |
|---|---|
| Beta | -0.114 |
| Beta Downside | -0.304 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.97% |
| CAGR/Max DD | 1.01 |
EPS (Earnings per Share)
Revenue
Description: NOC Northrop Grumman March 05, 2026
Northrop Grumman Corporation (NOC) is a U.S.-based aerospace and defense technology company with global operations. The companys business model centers on developing and producing advanced systems across four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems.
The Aeronautics Systems segment focuses on aircraft, including unmanned autonomous systems and strategic long-range aircraft. The Defense Systems segment provides strategic deterrent systems, tactical weapons, and missile defense solutions, alongside sustainment and modernization services. The Mission Systems segment delivers command, control, and intelligence systems, as well as various sensor and electronic warfare technologies. Finally, the Space Systems segment develops satellites, spacecraft, missile defense systems, and launch vehicles.
The aerospace and defense sector is characterized by long development cycles and significant government contract reliance. For a deeper dive into NOCs financial health and market position, ValueRay offers comprehensive analytical tools.
Headlines to watch out for
Government defense spending budgets dictate revenue growth | Global geopolitical tensions increase demand for defense products | Supply chain disruptions impact production and delivery schedules | Regulatory approvals crucial for new defense contracts | Inflationary pressures elevate material and labor costs
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 4.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.13 > 1.0 |
| NWC/Revenue: 2.90% < 20% (prev -0.10%; Δ 3.00% < -1%) |
| CFO/TA 0.09 > 3% & CFO 4.76b > Net Income 4.18b |
| Net Debt (15.34b) to EBITDA (7.21b): 2.13 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.9m) vs 12m ago -2.99% < -2% |
| Gross Margin: 19.81% > 18% (prev 0.20%; Δ 1961 % > 0.5%) |
| Asset Turnover: 83.29% > 50% (prev 83.13%; Δ 0.16% > 0%) |
| Interest Coverage Ratio: 8.62 > 6 (EBITDA TTM 7.21b / Interest Expense TTM 665.0m) |
Altman Z'' 2.48
| A: 0.02 (Total Current Assets 15.10b - Total Current Liabilities 13.88b) / Total Assets 51.38b |
| B: 0.32 (Retained Earnings 16.66b / Total Assets 51.38b) |
| C: 0.11 (EBIT TTM 5.73b / Avg Total Assets 50.37b) |
| D: 0.48 (Book Value of Equity 16.67b / Total Liabilities 34.70b) |
| Altman-Z'' Score: 2.48 = A |
Beneish M -2.91
| DSRI: 1.12 (Receivables 8.84b/7.70b, Revenue 41.95b/41.03b) |
| GMI: 1.03 (GM 19.81% / 20.38%) |
| AQI: 0.98 (AQ_t 0.46 / AQ_t-1 0.47) |
| SGI: 1.02 (Revenue 41.95b / 41.03b) |
| TATA: -0.01 (NI 4.18b - CFO 4.76b) / TA 51.38b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of NOC shares?
As of March 08, 2026, the stock is trading at USD 756.13 with a total of 771,528 shares traded.
Over the past week, the price has changed by +4.38%, over one month by +6.97%, over three months by +37.03% and over the past year by +61.68%.
Over the past week, the price has changed by +4.38%, over one month by +6.97%, over three months by +37.03% and over the past year by +61.68%.
Is NOC a buy, sell or hold?
Northrop Grumman has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy NOC.
- StrongBuy: 10
- Buy: 4
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NOC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 724.4 | -4.2% |
| Analysts Target Price | 724.4 | -4.2% |
NOC Fundamental Data Overview March 04, 2026
P/E Trailing = 26.3834
P/E Forward = 27.1003
P/S = 2.6127
P/B = 6.537
P/EG = 5.7609
Revenue TTM = 41.95b USD
EBIT TTM = 5.73b USD
EBITDA TTM = 7.21b USD
Long Term Debt = 15.16b USD (from longTermDebt, last quarter)
Short Term Debt = 865.0m USD (from shortTermDebt, last quarter)
Debt = 19.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.34b USD (from netDebt column, last quarter)
Enterprise Value = 124.95b USD (109.61b + Debt 19.74b - CCE 4.40b)
Interest Coverage Ratio = 8.62 (Ebit TTM 5.73b / Interest Expense TTM 665.0m)
EV/FCF = 37.78x (Enterprise Value 124.95b / FCF TTM 3.31b)
FCF Yield = 2.65% (FCF TTM 3.31b / Enterprise Value 124.95b)
FCF Margin = 7.88% (FCF TTM 3.31b / Revenue TTM 41.95b)
Net Margin = 9.97% (Net Income TTM 4.18b / Revenue TTM 41.95b)
Gross Margin = 19.81% ((Revenue TTM 41.95b - Cost of Revenue TTM 33.64b) / Revenue TTM)
Gross Margin QoQ = 19.60% (prev 21.37%)
Tobins Q-Ratio = 2.43 (Enterprise Value 124.95b / Total Assets 51.38b)
Interest Expense / Debt = 0.89% (Interest Expense 175.0m / Debt 19.74b)
Taxrate = 17.99% (313.0m / 1.74b)
NOPAT = 4.70b (EBIT 5.73b * (1 - 17.99%))
Current Ratio = 1.09 (Total Current Assets 15.10b / Total Current Liabilities 13.88b)
Debt / Equity = 1.18 (Debt 19.74b / totalStockholderEquity, last quarter 16.67b)
Debt / EBITDA = 2.13 (Net Debt 15.34b / EBITDA 7.21b)
Debt / FCF = 4.64 (Net Debt 15.34b / FCF TTM 3.31b)
Total Stockholder Equity = 15.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.30% (Net Income 4.18b / Total Assets 51.38b)
RoE = 26.50% (Net Income TTM 4.18b / Total Stockholder Equity 15.78b)
RoCE = 18.53% (EBIT 5.73b / Capital Employed (Equity 15.78b + L.T.Debt 15.16b))
RoIC = 15.32% (NOPAT 4.70b / Invested Capital 30.69b)
WACC = 4.77% (E(109.61b)/V(129.35b) * Re(5.50%) + D(19.74b)/V(129.35b) * Rd(0.89%) * (1-Tc(0.18)))
Discount Rate = 5.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.75%
[DCF] Terminal Value 88.22% ; FCFF base≈3.03b ; Y1≈3.65b ; Y5≈5.89b
[DCF] Fair Price = 1102 (EV 171.79b - Net Debt 15.34b = Equity 156.45b / Shares 141.9m; r=5.90% [WACC]; 5y FCF grow 21.82% → 2.90% )
EPS Correlation: 8.40 | EPS CAGR: 4.64% | SUE: 0.20 | # QB: 0
Revenue Correlation: 79.57 | Revenue CAGR: 7.93% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-06-30): EPS=6.82 | Chg7d=-0.021 | Chg30d=-0.183 | Revisions Net=-11 | Analysts=16
EPS current Year (2026-12-31): EPS=27.74 | Chg7d=+0.000 | Chg30d=-0.200 | Revisions Net=-19 | Growth EPS=+5.3% | Growth Revenue=+4.6%
EPS next Year (2027-12-31): EPS=30.04 | Chg7d=+0.000 | Chg30d=-0.546 | Revisions Net=-16 | Growth EPS=+8.3% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = +0.0% (Analyst 4.2% - Implied 4.2%)
P/E Forward = 27.1003
P/S = 2.6127
P/B = 6.537
P/EG = 5.7609
Revenue TTM = 41.95b USD
EBIT TTM = 5.73b USD
EBITDA TTM = 7.21b USD
Long Term Debt = 15.16b USD (from longTermDebt, last quarter)
Short Term Debt = 865.0m USD (from shortTermDebt, last quarter)
Debt = 19.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.34b USD (from netDebt column, last quarter)
Enterprise Value = 124.95b USD (109.61b + Debt 19.74b - CCE 4.40b)
Interest Coverage Ratio = 8.62 (Ebit TTM 5.73b / Interest Expense TTM 665.0m)
EV/FCF = 37.78x (Enterprise Value 124.95b / FCF TTM 3.31b)
FCF Yield = 2.65% (FCF TTM 3.31b / Enterprise Value 124.95b)
FCF Margin = 7.88% (FCF TTM 3.31b / Revenue TTM 41.95b)
Net Margin = 9.97% (Net Income TTM 4.18b / Revenue TTM 41.95b)
Gross Margin = 19.81% ((Revenue TTM 41.95b - Cost of Revenue TTM 33.64b) / Revenue TTM)
Gross Margin QoQ = 19.60% (prev 21.37%)
Tobins Q-Ratio = 2.43 (Enterprise Value 124.95b / Total Assets 51.38b)
Interest Expense / Debt = 0.89% (Interest Expense 175.0m / Debt 19.74b)
Taxrate = 17.99% (313.0m / 1.74b)
NOPAT = 4.70b (EBIT 5.73b * (1 - 17.99%))
Current Ratio = 1.09 (Total Current Assets 15.10b / Total Current Liabilities 13.88b)
Debt / Equity = 1.18 (Debt 19.74b / totalStockholderEquity, last quarter 16.67b)
Debt / EBITDA = 2.13 (Net Debt 15.34b / EBITDA 7.21b)
Debt / FCF = 4.64 (Net Debt 15.34b / FCF TTM 3.31b)
Total Stockholder Equity = 15.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.30% (Net Income 4.18b / Total Assets 51.38b)
RoE = 26.50% (Net Income TTM 4.18b / Total Stockholder Equity 15.78b)
RoCE = 18.53% (EBIT 5.73b / Capital Employed (Equity 15.78b + L.T.Debt 15.16b))
RoIC = 15.32% (NOPAT 4.70b / Invested Capital 30.69b)
WACC = 4.77% (E(109.61b)/V(129.35b) * Re(5.50%) + D(19.74b)/V(129.35b) * Rd(0.89%) * (1-Tc(0.18)))
Discount Rate = 5.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.75%
[DCF] Terminal Value 88.22% ; FCFF base≈3.03b ; Y1≈3.65b ; Y5≈5.89b
[DCF] Fair Price = 1102 (EV 171.79b - Net Debt 15.34b = Equity 156.45b / Shares 141.9m; r=5.90% [WACC]; 5y FCF grow 21.82% → 2.90% )
EPS Correlation: 8.40 | EPS CAGR: 4.64% | SUE: 0.20 | # QB: 0
Revenue Correlation: 79.57 | Revenue CAGR: 7.93% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-06-30): EPS=6.82 | Chg7d=-0.021 | Chg30d=-0.183 | Revisions Net=-11 | Analysts=16
EPS current Year (2026-12-31): EPS=27.74 | Chg7d=+0.000 | Chg30d=-0.200 | Revisions Net=-19 | Growth EPS=+5.3% | Growth Revenue=+4.6%
EPS next Year (2027-12-31): EPS=30.04 | Chg7d=+0.000 | Chg30d=-0.546 | Revisions Net=-16 | Growth EPS=+8.3% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = +0.0% (Analyst 4.2% - Implied 4.2%)